tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Priya Sachdeva, 7 are a BUY (100%).
Analyst Priya Sachdeva, currently employed at UBS, carries an average stock price target met ratio of 83.33% that have a potential upside of 30.31% achieved within 244 days.
Priya Sachdeva’s has documented 14 price targets and ratings displayed on 2 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on NPCE, Neuropace at 16-Dec-2025.
Analyst best performing recommendations are on NPCE (NEUROPACE).
The best stock recommendation documented was for NPCE (NEUROPACE) at 1/21/2025. The price target of $17 was fulfilled within 114 days with a profit of $3.94 (30.17%) receiving and performance score of 2.65.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-May-2025
$20
$5.96 (42.45%)
$20
1 months 19 days ago
(29-Jul-2026)
2/4 (50%)
$6.36 (46.63%)
222
Buy Since 21-Jan-2025
$22
$5.53 (33.58%)
$18
9 months 1 days ago
(16-Dec-2025)
2/3 (66.67%)
$6.12 (38.54%)
221
Buy Since 08-Nov-2023
$20
$3.53 (21.43%)
$16
9 months 7 days ago
(10-Dec-2025)
4/5 (80%)
$3.22 (19.19%)
126
Buy Since 29-May-2024
$16
$-0.47 (-2.85%)
$15
10 months 12 days ago
(05-Nov-2025)
7/10 (70%)
$3.02 (23.27%)
146
Buy Since 10-Nov-2023
$16
$-0.47 (-2.85%)
$16
1 years 8 days ago
(09-Sep-2025)
10/13 (76.92%)
$6.03 (60.48%)
135
What Year was the first public recommendation made by Priya Sachdeva?
